Chlorzoxazone - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for chlorzoxazone and what is the scope of patent protection?

Chlorzoxazone is the generic ingredient in four branded drugs marketed by Acme Labs, Actavis Elizabeth, Aurobindo Pharma Ltd, Barr, Belcher, Chartwell Rx, Corepharma, Dr Reddys Labs Sa, Endo Operations, Glenmark Pharms Ltd, Mikart, Novitium Pharma, Ohm Labs, Pioneer Pharms, Rising, Senores Pharms, Strides Pharma, Sun Pharm Industries, Teva Pharms Usa Inc, Upsher Smith Labs, Watson Labs, Ortho Mcneil Pharm, Janssen R And D, and Ferndale Labs, and is included in thirty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for chlorzoxazone. Twenty-five suppliers are listed for this compound.

Summary for chlorzoxazone

US Patents:	0
Tradenames:	4
Applicants:	24
NDAs:	38
Drug Master File Entries:	16
Finished Product Suppliers / Packagers:	25
Raw Ingredient (Bulk) Api Vendors:	137
Clinical Trials:	10
Patent Applications:	5,547
Drug Prices:	Drug price trends for chlorzoxazone
What excipients (inactive ingredients) are in chlorzoxazone?	chlorzoxazone excipients list
DailyMed Link:	chlorzoxazone at DailyMed

See drug prices for chlorzoxazone

Recent Clinical Trials for chlorzoxazone

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Tufts University	Phase 1
University of Texas Southwestern Medical Center	Phase 1
University Hospital Olomouc	Phase 2

See all chlorzoxazone clinical trials

Pharmacology for chlorzoxazone

Drug Class	Muscle Relaxant
Physiological Effect	Centrally-mediated Muscle Relaxation

Medical Subject Heading (MeSH) Categories for chlorzoxazone

Muscle Relaxants, Central

Anatomical Therapeutic Chemical (ATC) Classes for chlorzoxazone

M03BB	Oxazol, thiazine, and triazine derivatives
M03B	MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
M03	MUSCLE RELAXANTS
M	Musculo-skeletal system

US Patents and Regulatory Information for chlorzoxazone

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Rx	CHLORZOXAZONE	chlorzoxazone	TABLET;ORAL	212053-002	Sep 14, 2020		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Upsher Smith Labs	CHLORZOXAZONE	chlorzoxazone	TABLET;ORAL	212047-001	Jan 27, 2023	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Pharms Usa Inc	CHLORZOXAZONE	chlorzoxazone	TABLET;ORAL	212898-002	Jun 17, 2020		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.